Myeloma

FDA’s ODAC Endorses New Indications for 2 CAR-T Therapies for Myeloma

Image of a droplet_dam_file_177236.jpg

FDA’s Recent Approval of 2 CAR T-Cell Therapies a ‘Big Step Toward’ Long-Term Control of Myeloma for More Patients

Global Partnership to Fund Groundbreaking Research in Treatment of Multiple Myeloma

banner-list-news.jpg

Latest FDA Approval in Multiple Myeloma May Reduce Treatment Costs, Frequency and Side Effects

fda approval 3_dam_file_106401.jpg

Recent FDA Approval Gives More Myeloma Patients Chance at Long-Term Remission with a Stem Cell Transplant

Blood cancer facts and statistics

Blood Cancer United National Patient Registry

Sexual health side effects in young adults

Blood tests and urinalysis

Myeloma

FDA’s ODAC Endorses New Indications for 2 CAR-T Therapies for Myeloma

FDA’s Recent Approval of 2 CAR T-Cell Therapies a ‘Big Step Toward’ Long-Term Control of Myeloma for More Patients

Global Partnership to Fund Groundbreaking Research in Treatment of Multiple Myeloma

Latest FDA Approval in Multiple Myeloma May Reduce Treatment Costs, Frequency and Side Effects

Recent FDA Approval Gives More Myeloma Patients Chance at Long-Term Remission with a Stem Cell Transplant

Blood cancer facts and statistics

Blood Cancer United National Patient Registry

Suggested reading

Sexual health side effects in young adults

Blood tests and urinalysis

Myeloma